We show that hNVs@Flu-EGCG, which inherit the major capabilities from source cells, efficiently reprogramme TAMs toward M1 phenotype to inhibit tumor growth and suppress NF-κB pathway to promote cancer cells apoptosis (Fig. 1B). Here, NFKB1 is linked to cancer.